$RGEN
Price history, market instrument context, member research, and related headlines in one place.
RGEN key statistics
NasdaqGSUSD
52-week range
$100.9979%$198.87
Latest session $175.39–$181.07Repligen Corporation (RGEN) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $178.20, up $2.78 (1.58%) from the previous close of $175.42. It has traded between $175.39 and $181.07 in the latest session. Over the past year it has ranged from $100.99 to $198.87, leaving it in the upper quarter of its 52-week range (79%). Reported volume for the session was 1.2M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Repligen soars 16% after blockbuster earnings, FY25 guidance upgrade — See source for full details.
Repligen projects $813M-$834M 2026 revenue amid BioLife deal and raised $2.03-$2.09 EPS — See source for full details.
Repligen beats estimates but shares dip on guidance concerns — See source for full details.
Repligen Non-GAAP EPS of $0.54 beats by $0.09, revenue of $204.1M beats by $2.7M — See source for full details.
Loading $RGEN research…